New Key Statistics Module, Z-Score and F-Score
NAS:SLN Key Ratios
| Market Cap $ M | 866.27 |
| Enterprise Value $ M | 676.18 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.38 |
| Price/Sales | 36.48 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 22.00 |
| EPS (TTM) $ | -1.23 |
| Beneish M-Score | -3.27 |
| 10-y EBITDA Growth Rate % | -11.40 |
| 5-y EBITDA Growth Rate % | -10.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.68 |
| EV-to-EBITDA | -11.80 |
| PEG | -- |
| Shares Outstanding M | 46.80 |
| Net Margin (%) | -223.61 |
| Operating Margin % | -270.01 |
| Pre-tax Margin (%) | -258.79 |
| Quick Ratio | 9.83 |
| Current Ratio | 9.83 |
| ROA % (ttm) | -30.00 |
| ROE % (ttm) | -69.87 |
| ROIC % (ttm) | -149.50 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.58 |
SLN Number of Guru Trades
SLN Volume of Guru Trades
Gurus Latest Trades with NAS:SLN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SLN is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Silence Therapeutics PLC Insider Transactions
No Available Data
News about NAS:SLN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers